| Product Code: ETC13370233 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Middle East Vaccine Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Middle East Vaccine Market Overview |
3.1 Middle East Regional Macro Economic Indicators |
3.2 Middle East Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Middle East Vaccine Market - Industry Life Cycle |
3.4 Middle East Vaccine Market - Porter's Five Forces |
3.5 Middle East Vaccine Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Middle East Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Middle East Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 Middle East Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Middle East Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Middle East Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 Middle East Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Middle East Vaccine Market Trends |
6 Middle East Vaccine Market, 2021 - 2031 |
6.1 Middle East Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Middle East Vaccine Market, Revenues & Volume, By Preventive Vaccines, 2021 - 2031 |
6.1.3 Middle East Vaccine Market, Revenues & Volume, By Therapeutic Vaccines, 2021 - 2031 |
6.1.4 Middle East Vaccine Market, Revenues & Volume, By DNA Vaccines, 2021 - 2031 |
6.2 Middle East Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Middle East Vaccine Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.2.3 Middle East Vaccine Market, Revenues & Volume, By COVID19, 2021 - 2031 |
6.2.4 Middle East Vaccine Market, Revenues & Volume, By Hepatitis B, 2021 - 2031 |
6.3 Middle East Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Middle East Vaccine Market, Revenues & Volume, By Pediatrics, 2021 - 2031 |
6.3.3 Middle East Vaccine Market, Revenues & Volume, By Adults, 2021 - 2031 |
6.3.4 Middle East Vaccine Market, Revenues & Volume, By Geriatrics, 2021 - 2031 |
6.4 Middle East Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Middle East Vaccine Market, Revenues & Volume, By Intramuscular, 2021 - 2031 |
6.4.3 Middle East Vaccine Market, Revenues & Volume, By Subcutaneous, 2021 - 2031 |
6.4.4 Middle East Vaccine Market, Revenues & Volume, By Oral, 2020 - 2028 |
6.5 Middle East Vaccine Market, Revenues & Volume, By Technology, 2020 - 2028 |
6.5.1 Overview & Analysis |
6.5.2 Middle East Vaccine Market, Revenues & Volume, By mRNAbased, 2020 - 2028 |
6.5.3 Middle East Vaccine Market, Revenues & Volume, By Viral Vector, 2020 - 2028 |
6.5.4 Middle East Vaccine Market, Revenues & Volume, By Protein Subunit, 2020 - 2028 |
7 Middle East Vaccine Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Middle East Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.1 Saudi Arabia Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.2 UAE Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.3 Kuwait Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.4 Qatar Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.5 Bahrain Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.6 Oman Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.7 Turkey Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.2.8 Rest of Middle East Vaccine Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3 Middle East Vaccine Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
7.3.1 Saudi Arabia Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.2 UAE Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.3 Kuwait Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.4 Qatar Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.5 Bahrain Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.6 Oman Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.7 Turkey Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.3.8 Rest of Middle East Vaccine Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4 Middle East Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.1 Saudi Arabia Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.2 UAE Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.3 Kuwait Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.4 Qatar Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.5 Bahrain Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.6 Oman Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.7 Turkey Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.4.8 Rest of Middle East Vaccine Market, Revenues & Volume, By Age Group, 2021 - 2031 |
7.5 Middle East Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.1 Saudi Arabia Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.2 UAE Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.3 Kuwait Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.4 Qatar Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.5 Bahrain Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.6 Oman Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.7 Turkey Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.8 Rest of Middle East Vaccine Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 Middle East Vaccine Market, Revenues & Volume, By Technology, 2020 - 2028 |
7.6.1 Saudi Arabia Vaccine Market, Revenues & Volume, By Technology, 2020 - 2028 |
7.6.2 UAE Vaccine Market, Revenues & Volume, By Technology, 2020 - 2028 |
7.6.3 Kuwait Vaccine Market, Revenues & Volume, By Technology, 2020 - 2028 |
7.6.4 Qatar Vaccine Market, Revenues & Volume, By Technology, 2020 - 2028 |
7.6.5 Bahrain Vaccine Market, Revenues & Volume, By Technology, 2020 - 2028 |
7.6.6 Oman Vaccine Market, Revenues & Volume, By Technology, 2020 - 2028 |
7.6.7 Turkey Vaccine Market, Revenues & Volume, By Technology, 2020 - 2028 |
7.6.8 Rest of Middle East Vaccine Market, Revenues & Volume, By Technology, 2020 - 2028 |
8 Middle East Vaccine Market Key Performance Indicators |
9 Middle East Vaccine Market - Export/Import By Countries Assessment |
10 Middle East Vaccine Market - Opportunity Assessment |
10.1 Middle East Vaccine Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Middle East Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
10.3 Middle East Vaccine Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10.4 Middle East Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
10.5 Middle East Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.6 Middle East Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
11 Middle East Vaccine Market - Competitive Landscape |
11.1 Middle East Vaccine Market Revenue Share, By Companies, 2022 |
11.2 Middle East Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here